Molecular targets of lithium action.

Area of Science:

• Biochemistry
• Pharmacology
• Cell Biology

Background:

• Lithium is a cornerstone treatment for bipolar disorder.
• Its broad effects on cellular processes, including embryonic development and metabolism, are well-documented.
• The exact molecular mechanisms underlying lithium's therapeutic and side effects are not fully understood.

Purpose of the Study:

• To review lithium-sensitive enzymes as potential targets for lithium's diverse biological actions.
• To discuss criteria for validating enzyme targets in lithium's cellular response.
• To clarify the mechanism of lithium action in various biological settings.

Main Methods:

• Literature review of studies investigating lithium's effects on enzymes.
• Analysis of enzyme characteristics, including metal ion dependence and inhibition patterns.
• Evaluation of genetic and pharmacological approaches to validate enzyme targets.

Main Results:

• Several enzymes, including inositol monophosphatase and glycogen synthase kinase-3, are proposed lithium targets.
• These enzymes are widely expressed and inhibited by lithium, likely via divalent cation displacement.
• Genetic and pharmacological studies provide evidence for or against specific enzyme targets.

Conclusions:

• Identifying the specific enzyme target responsible for a given lithium response is a significant challenge.
• A systematic approach using comparative studies and alternative inhibitors is crucial for mechanistic insights.
• Understanding these enzyme interactions is key to elucidating lithium's complex biological roles.